Smartphone-enabled Health Coaching Intervention for Youth Diagnosed With Major Depressive Disorders

Sponsor
York University (Other)
Overall Status
Suspended
CT.gov ID
NCT03406052
Collaborator
Centre for Addiction and Mental Health (Other)
168
1
2
16.3
10.3

Study Details

Study Description

Brief Summary

Randomized controlled trial (RCT) comparing youth diagnosed with major depressive disorder treated with online mindfulness-based cognitive behavioural therapy vs. standard psychiatric care (as wait-list controls). Eligible subjects will be recruited from the wait-lists of the Centre for Addiction and Mental Health. N = 168 subjects will consist of youth from First Nations background (18-30 yrs) and youth from all other ethnic backgrounds stratified to two intervention groups and two wait-list control groups consisting of 50% First Nations youth and 50% youth of all other ethnic backgrounds.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Smartphone-Assisted MB-CBT
N/A

Detailed Description

A high proportion (70%) of mental health problems appear before 25 yrs. and can become become long-standing, significant disorders that impair all life domains. Early signs of disorder left untreated is an acute problem for Canadian youth as 15-25 yrs is the most likely age-strata for diagnosable psychiatric disorders, substance dependencies and suicide. Progress in youth treatments that engage the tendencies of youth to respond to online internet contact are likely to be especially strategic.

In this randomized controlled trial (RCT) diagnosed depressed youth are treated with online mindfulness-based cognitive behavioural therapy (MB-CBT) and standard psychiatric care or just standard psychiatric care (as wait-list controls). Eligible subjects will be recruited from the wait-lists of the Centre for Addiction and Mental Health (CAMH), and from community-based practices and clinics proximal to CAMH. The consented 168 subjects will be from First Nations background (18-30 yrs) and from all other ethnic backgrounds, stratified into two intervention groups and two wait-list control groups.

Primary outcome is self reported depression using the Beck Depression Inventory II while secondary outcomes include self reported anxiety (Beck Anxiety Inventory), depression (Quick Inventory of Depressive Symptomatology, 24-item Hamilton Rating Scale for Depression (HRSD-24)), pain (Brief Pain Inventory) mindfulness (Five-Facet Mindfulness Questionnaire) and intervention costs.

If hypotheses are confirmed that youth can be effectively treated with online MB-CBT at reduced costs, effective treatment can be delivered to greater numbers with less geographic restriction.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
168 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Masking Description:
Psychiatrists providing psychiatric care will be blinded to the group allocation of subjects under their treatment. One outcome assessor (who will conduct the 24-item Hamilton Rating Scale for Depression (HRSD-24) will be blinded. Investigators will be blinded.
Primary Purpose:
Supportive Care
Official Title:
An Innovative Smartphone-enabled Health Coaching Intervention for Youth Diagnosed With Major Depressive Disorders
Actual Study Start Date :
Jan 19, 2018
Actual Primary Completion Date :
Mar 31, 2019
Anticipated Study Completion Date :
May 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Smartphone-Assisted MB-CBT

Online intervention accessed through smartphone or online accessed computer comprised of Mindfulness-Based Cognitive Behaviour content

Behavioral: Smartphone-Assisted MB-CBT
Experimental subjects will receive a mindfulness-based CBT online software program workbook (in collaboration with Nex J Systems, Inc.) accessible online. Exposure to and interaction with the online workbook is combined with health coaching (duration of 24 total hours) primarily delivered in phone and software interactions. In addition, each participant will be given a Fitbit-HR Charge, a wearable bracelet that assesses physical steps and 24 hour heart rate in 5 second (averaged) durations (with related access to software that permits daily tracking).

No Intervention: Control

Standard psychiatric care

Outcome Measures

Primary Outcome Measures

  1. Beck Depression Inventory II [Baseline, 3 months, 6 months]

    Change from baseline self report of symptoms of depression

Secondary Outcome Measures

  1. Beck Anxiety Scale [Baseline, 3 months, 6 months]

    Change from baseline self report of anxiety symptoms

  2. Quick Inventory of Depressive Symptomatology [Baseline, 3 months, 6 months]

    Change from baseline self report of symptoms of depression

  3. Hamilton Depression Rating Scale (HRDS-24) [Baseline, 3 months, 6 months]

    Change from baseline interview and interviewer rating of symptoms of depression

  4. Five-Facet Mindfulness Questionnaire [Baseline, 3 months, 6 months]

    Change from baseline self report of mindfulness experience

  5. Brief Pain Inventory [Baseline, 3 months, 6 months]

    Change from baseline self report of pain intensity

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  • 18-30 yrs

  • First Nations background or other ethnicity

  • BDI-II at mild-moderate levels (i.e., BDI-II score ≥ 14 and < 29 )

  • diagnosis of major depressive disorder

  • fluent in english

  • diagnosis by a CAMH physician and diagnosis confirmed by a MINI International Neuropsychiatric Interview

Exclusion Criteria

  • < 18 yrs and > 30 yrs

  • BDI-II in severe range ≥ 29 or < 14

  • does not qualify for diagnosis of major depressive disorder or diagnosis not confirmed by MINI International Neuropsychiatric Interview

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre for Addiction and Mental Health Toronto Ontario Canada M6J 1H4

Sponsors and Collaborators

  • York University
  • Centre for Addiction and Mental Health

Investigators

  • Principal Investigator: Paul G Ritvo, PhD, York University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Paul Ritvo, Professor, York University
ClinicalTrials.gov Identifier:
NCT03406052
Other Study ID Numbers:
  • Yorku
  • 2016-115
  • 2017-154
First Posted:
Jan 23, 2018
Last Update Posted:
Apr 23, 2019
Last Verified:
Apr 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 23, 2019